Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CVS Pharmacy, Inc. et al v. Warner Chilcott Public Limited Company et al
Case Number:
1:16-cv-00164
Court:
Nature of Suit:
Judge:
Firms
Companies
- Allergan PLC
- CVS Health Corp.
- Lupin Ltd.
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- Warner Chilcott Limited
Sectors & Industries:
-
May 10, 2016
Loestrin Buyers Allege Product-Hopping By Warner Chilcott
Direct and indirect purchasers of the contraceptive Loestrin filed amended complaints in Rhode Island federal court Monday in the pay-for-delay multidistrict litigation against Warner Chilcott Ltd., newly alleging that the drug giant engaged in a product-hopping scheme to exclude competitors from the relevant market.
-
April 06, 2016
CVS, Rite Aid Hit Warner Chilcott With Loestrin Antitrust Suit
CVS and Rite Aid on Tuesday told a Rhode Island federal court that Warner Chilcott Ltd. illegally paid Watson Pharmaceuticals and Lupin Pharmaceuticals to delay the entry of generic versions of the birth control pill Loestrin, and then switched to chewable tablets that further extend their exclusivity without medical benefit.